Press Releases
(EMAILWIRE.COM, March 24, 2024 ) As per Maximize Market research, the Australia Healthcare Insurance Market was USD 26.51 Million in 2023 and is expected to grow at a CAGR of 9.2 percent over the forecast period to reach USD 49.09 Billion by 2030.
Australia Healthcare Insurance Market Report Scope...more
(EMAILWIRE.COM, March 24, 2024 ) As per Maximize Market research, the DNA Data Storage Market was USD 43.76 Million in 2023 and is expected to grow at a CAGR of 85.4 percent over the forecast period to reach USD 3295 Million by 2030.
DNA Data Storage Market Report Scope and Research Methodology
The...more
(EMAILWIRE.COM, March 23, 2024 ) As per Maximize Market research, the Mexico Healthcare Insurance Market was USD 35.40 Billion in 2023 and is expected to grow at a CAGR of 9.12 percent over the forecast period to reach USD 65.24 Billion by 2030.
Mexico Healthcare Insurance Market Report Scope...more
(EMAILWIRE.COM, March 23, 2024 ) As per Maximize Market research, the Japan Medical and Diagnostic Laboratory Services Market was USD 15.99 Billion in 2023 and is expected to grow at a CAGR of 5.4 percent over the forecast period to reach USD 23.11 Billion by 2030.
Japan Medical and Diagnostic...more
(EMAILWIRE.COM, March 23, 2024 ) As per Maximize Market research, the US Healthcare Insurance Market was USD 887 Billion in 2023 and is expected to grow at a CAGR of 6.2 percent over the forecast period to reach USD 1351 Billion by 2030.
US Healthcare Insurance Market Report Scope and Research...more
(EMAILWIRE.COM, March 22, 2024 ) As per Maximize Market research, the US Growth Hormone Deficiency Clinical Trials Market was USD 530 Million in 2023 and is expected to grow at a CAGR of 5.52 percent over the forecast period to reach USD 772 Million by 2030.
US Growth Hormone Deficiency Clinical...more
(EMAILWIRE.COM, March 22, 2024 ) As per Maximize Market research, the Japan Growth Hormone Deficiency Clinical Trial Market was USD 225.18 Million in 2023 and is expected to grow at a CAGR of 5.1 percent over the forecast period to reach USD 318.97 Million by 2030.
Japan Growth Hormone Deficiency...more
(EMAILWIRE.COM, March 22, 2024 ) As per Maximize Market research, the Germany Growth Hormone Deficiency Clinical Trial Market was USD 72 Million in 2023 and is expected to grow at a CAGR of 4.2 percent over the forecast period to reach USD 96.03 Million by 2030.
Germany Growth Hormone Deficiency...more
(EMAILWIRE.COM, March 17, 2024 ) As per Maximize Market research, the Malaysia Nutritional Supplements Market was USD 644.88 Million in 2023 and is expected to grow at a CAGR of 5.2 percent over the forecast period to reach USD 919.58 Million by 2030.
Malaysia Nutritional Supplements Market Report...more
(EMAILWIRE.COM, March 17, 2024 ) As per Maximize Market research, the Japan Oncology Drugs Market was USD 13.68 Billion in 2023 and is expected to grow at a CAGR of 12.3 percent over the forecast period to reach USD 30.81 Billion by 2030.
Japan Oncology Drugs Market Report Scope and Research Methodology
The...more
